Early Access — free while we kick the tires
EdgarHawk

BCRX BIOCRYST PHARMACEUTICALS INC Insider Trading

Latest: CLO Sold $596K of Shares · May 2026
1 filing analyzed · Latest 2026-05-15
Insider buys
0
Insider sells
1
Unique insiders
1
Direction
Net selling
May 2026
2026-05-15
low
Barnes Alane P Sell
Chief Legal Officer
62,500 shares
$596,250
@ $9.54
Significance 4/10

Chief Legal Officer Barnes sold 62,500 shares at $5.04 and $9.54 for $596,250.00 under scheduled 10b5-1 plan.

Barnes Alane P, Chief Legal Officer, executed 2 separate sales totaling 62,500 shares for $596,250.00 on 2026-05-13 as part of a pre-arranged 10b5-1 trading plan adopted on 2025-08-13, making this a scheduled, non-discretionary transaction. Post-transaction, Barnes retains 400,703 shares, down from 463,203 shares. Because this transaction is governed by a 10b5-1 plan, it reflects a pre-scheduled execution rather than a discretionary timing decision. BCRX reported revenue of $156,413,000.00 in the latest quarter and annual revenue growth of 94.1%, though the company posted a net loss of $-721,812,000.00, indicating significant cash burn despite top-line expansion.

More Chemicals and Allied Products companies

Get alerts for BCRX

Add BCRX to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access